Court OKs $40M Paxil Deal With Third-Party Payors
A federal judge has granted final approval to a $40 million class action settlement between GlaxoSmithKline PLC and a group of health care funds and insurance companies that sued to recover...To view the full article, register now.
Already a subscriber? Click here to view full article